Effects of vitamin D3 supplementation on lipid profile and renal indices in rat model of drug induced renal injury
DOI:
https://doi.org/10.15584/ejcem.2024.4.7Keywords:
adriamycin, chronic kidney disease, dyslipidemia, oxidative stress, renal injury, vitamin DAbstract
Introduction and aim. Renal injury is associated with decreased renal function, hypovitaminosis D, deranged calcium-phos phate metabolism and dyslipidemia, thus increasing risk for chronic kidney disease and cardiovascular diseases. However, re ports on the effects of vitamin D on drug induced renal injury are few. The aim was to investigate the possible role of vitamin D supplementation in reversing deranged lipid profile and renal function post drug induced renal injury.
Material and methods. Wister male rats (36) were randomly divided into group 1, 2 and 3 (n=12). Single dose of Adriamycin was given to all except group 1(control) to induce renal injury. Group 2 left untreated, group 3 given vitamin D3 for 28 days. Serum urea, creatinine, total protein, total cholesterol (TC), triglycerides (TG), LDL-C, HDL, apolipoprotein (Apo) A and B were measured. C-reactive protein (CRP) and nitric oxide were assessed in kidney homogenate.
Results. Vitamin D3 significantly brought down levels of serum creatinine, TC, LDL CRP, nitric oxide and increased the levels of Apo A, albumin, HDL. Serum urea, TG and Apo B in group 3 were not significantly different after vitamin D3 administration. His tological examination revealed improvement in glomerular messangialisation.
Conclusion. Vitamin D3 may improve renal health, through its positive impact on dyslipidemia, inflammation, and oxidative stress in drug induced renal injury.
Downloads
References
Navaneethan SD, Zoungas S, Caramori ML, et al. Diabetes Management in Chronic Kidney Disease: Synopsis of the 2020 KDIGO Clinical Practice Guideline. Ann Intern Med. 2021;174(3):385-394. doi: 10.7326/M20-5938
Sandeep A, Elumalai K, Williams H, Salkapuram S, Anandakumar S, Srinivasan S. Prevalence, prescription patterns, and quality of life of anaemia in adults with chronic renal disease. Eur J Clin Exp Med. 2023;21(4):785-792. doi: 10.15584/ejcem.2023.4.20
Hill NR, Fatoba ST, Oke JL, et al. Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis. PLoS One. 2016;11(7):e0158765. doi: 10.1371/journal.pone.0158765
Abd ElHafeez S, Bolignano D, D’Arrigo G, Dounousi E, Tripepi G, Zoccali C. Prevalence and burden of chronic kidney disease among the general population and high-risk groups in Africa: a systematic review. BMJ Open. 2018;8(1):e015069. doi: 10.1136/bmjopen-2016-015069
Bello AK, Alrukhaimi M, Ashuntantang GE, et al. Complications of chronic kidney disease: current state, knowledge gaps, and strategy for action. Kidney Int Suppl. 2011;(2):122-129. doi: 10.1016/j.kisu.2017.07.007
Kent S, Schlackow I, Lozano-Kuhne J, et al. What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease? BMC Nephrol. 2015;16:65. doi: 10.1186/s12882-015-0054-0
Levin A, Tonelli M, Bonventre J, et al. Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. Lancet. 2017;390(10105):1888-1917. doi: 10.1016/S0140-6736(17)30788-2
Miladiyah I, Yuanita E, Satyo N. et al. Synergistic Effect of 1,3,6-Trihydroxy-4,5,7-Trichloroxanthone in Combination with Doxorubicin on B-Cell Lymphoma Cells and Its Mechanism of Action Through Molecular Docking. Curr Ther Res Clin Exp. 2020;92:100576. doi: 10.1016/j.curtheres.2020.100576
Sritharan S, Sivalingam N. A comprehensive review on time-tested anticancer drug doxorubicin. Life Sci. 2021;1;278:119527. doi: 10.1016/j.lfs.2021.119527
Jankowski J, Floege J, Fliser D, Böhm M, Marx N. Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options. Circulation. 2021;143(11):1157-1172. doi: 10.1161/CIRCULATIONAHA.120.050686
Mikolasevic I, Žutelija M, Mavrinac V, Orlic L. Dyslipidemia in patients with chronic kidney disease: etiology and management. Int J Nephrol Renovasc Dis. 2017;7(10):35-45. doi: 10.2147/IJNRD.S101808.
Hsu CY, Chen LR, Chen KH. Osteoporosis in Patients with Chronic Kidney Diseases: A Systemic Review. Int J Mol Sci. 2020;21(18):6846. doi: 10.3390/ijms21186846.
Cameron LK, Ledwaba-Chapman L, Voong K, et al. Vitamin D metabolism in critically ill patients with acute kidney injury: a prospective observational study. Crit Care. 2024;28:108. doi: 10.1186/s13054-024-04869-4
Lucisano S, Buemi M, Passantino A, Aloisi C, Cernaro V, Santoro D. New insights on the role of vitamin D in the progression of renal damage. Kidney Blood Press Res. 2013; 37(6):667-678. doi: 10.1159/000355747
Mendes AKB, Sulis PM, Cavalari FC, et al. 1α,25-(OH)2 vitamin D3 prevents insulin resistance and regulates coordinated exocytosis and insulin secretion. J Nutr Biochem. 2022;99:108864. doi: 10.1016/j.jnutbio.2021.108864
Sonuga AA, Asaolu MF, Oyeyemi AO, Sonuga OO. Effects of Vitamin D3 Supplementation on Antioxidant Status and Lipid Peroxidation Product in Preeclamptic Women. J Gynecol. 2019;4(1):000169.
Mirković K, de Borst M. Beyond the RAAS: dissecting the antifibrotic effects of vitamin D analogues. Lab Invest. 2012;92:1666-1669. doi: 10.1038/labinvest.2012.150
Doumas BT, Peters T. Origins of dye-binding methods for measuring serum albumin. Clin Chem. 2009;55(3):583-584.
Tietz NW. Clinical Guide to Laboratory Tests. 3rd Edition. WB Saunders Company. Philadelphia. PA.1995; pp 518-519.
Murray RL. Creatinine. Kaplan A, et al. Clin Chem .The C.V. Mosby Co. St Louis. Toronto. Princeton. 1984; 1261-1266 and 418.
Fawcett JK, Scott JE. A rapid and precise method for the determination of urea. J Clin Pathol. 1960;13(2):156-159. doi: 10.1136/jcp.13.2.156
TIETZ N.W. Textbook of clinical chemistry, 3rd Ed. C.A. Burtis, E.R. Ashwood, W.B. Saunders.1999; p.493, p.481
Ridnour LA, Sim JE, Hayward MA, et al. A Spectrophotometric Method for the Direct Detection and Quantitation of Nitric Oxide, Nitrite, and Nitrate in Cell Culture Media. Analytical Biochemistry. 2000;281(2):223-229. doi: 10.1006/abio.2000.4583
Allan C, Deacon et Peter JG Dawson, Clin. Chem. 1979; 25(6), p.976-984
Lopes-Virella MF, Stone P, Ellis S, Colwell JA. Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem. 1977;23:882-884.
Trinder P. Enzymatic calorimetric determination of triglycerides by GOP-PAP method. Ann. ClinBiochem. 1969;6:24-27.
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 1972;18:499-502.
Brustolin D, Maierna M, Aguzzi F, Zoppi F, Tarenghi G, Berti G. Immunoturbidimetric method for routine determinations of apolipoproteins A-I and B. Clin Chem.1991;37(5):742-747.
Avwioro OG. Histochemistry and tissue pathology, principle and technique. Claverianum Press, 2010. Nigeria
Romero-Márquez J, Badillo-Carrasco A, Navarro-Hortal M, Rivas García L, Jiménez-Trigo V, Varela-López A. Nutritional interventions based on dietary restriction and nutrient reductions for the prevention of doxorubicin chemotherapy side effects. Mediterranean Journal of Nutrition and Metabolism. 2021;14:1-12. doi: 10.3233/MNM-210020
Javaid B, Olson JL, Meyer TW. Glomerular injury and tubular loss in adriamycin nephrosis. J Am Soc Nephrol. 2001;12(7):1391-1400. doi:10.1681/ASN.V1271391
Wang J-H, Keisala T, Solakivi T, Minasyan A, Kalueff AV, Tuohimaa P. Serum cholesterol and expression of ApoAI, LXRbeta and SREBP2 in vitamin D receptor knock-out mice. J Steroid Biochem Mol Biol England. 2009;113:222-226.
Abbas MA. Physiological functions of Vitamin D in adipose tissue. J Steroid Biochem Mol Biol. 2017;165(Pt B):369-381. doi:10.1016/j.jsbmb.2016.08.004
Chou SH, Murata EM, Yu C, et al. Effects of Vitamin D3 Supplementation on Body Composition in the Vitamin D and Omega-3 TriaL (VITAL). J Clin Endocrinol Metab. 2021;106(5):1377-1388.
Khosravi ZS, Kafeshani M, Tavasoli P, Zadeh AH, Entezari MH. Effect of Vitamin D Supplementation on Weight Loss, Glycemic Indices, and Lipid Profile in Obese and Overweight Women: A Clinical Trial Study. Int J Prev Med. 2018;20(9):63.
Al-Naimi MS, Rasheed HA, Hussien NR, Al-Kuraishy HM, Al-Gareeb AI. Nephrotoxicity: Role and significance of renal biomarkers in the early detection of acute renal injury. J Adv Pharm Technol Res. 2019;0(3):95-99. doi: 10.4103/japtr.JAPTR_336_18
Kurt E, Kurt SZE. Predictive value of blood urea nitrogen to serum albumin ratio in estimating in-hospital mortality in patients with upper gastrointestinal bleeding. Eur J Clin Exp Med. 2022;20(3):342-347. doi: 10.15584/ejcem.2022.3.13
Yasuda K, Park HC, Ratliff B, et al. Adriamycin nephropathy: a failure of endothelial progenitor cell-induced repair. Am J Pathol. 2010;176(4):1685-1695. doi: 10.2353/ajpath.2010.091071
Liyanage P, Lekamwasam S, Weerarathna TP, Liyanage C. Effect of Vitamin D therapy on urinary albumin excretion, renal functions, and plasma renin among patients with diabetic nephropathy: A randomized, double-blind clinical trial. J Postgrad Med. 2018;64(1):10-15. doi: 10.4103/jpgm.JPGM_598_16.
Vaidya A, Williams JS. The relationship between vitamin D and the renin-angiotensin system in the pathophysiology of hypertension, kidney disease, and diabetes. Metabolism. 2012;61(4):450-458. doi: 10.1016/j.metabol.2011.09.007
Gorriz JL, Martinez-Castelao A. Proteinuria: detection and role in native renal disease progression. Transplant Rev. 2012;26(1):3-13. doi: 10.1016/j.trre.2011.10.002
Lei M, Liu Z, Guo J. The Emerging Role of Vitamin D and Vitamin D Receptor in Diabetic Nephropathy. Biomed Res Int. 2020;11:4137268. doi: 10.1155/2020/4137268
De Zeeuw D, Agarwal R, Amdahl M. Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial. Lancet. 2010;376:1543-1551. doi: 10.1016/S0140-6736(10)61032-X
Agarwal R, Hynson JE, Hecht TJ, Light RP, Sinha AD. Short-term vitamin D receptor activation increases serum creatinine due to increased production with no effect on the glomerular filtration rate. Kidney Int. 2011;80(10):1073-1079. doi: 10.1038/ki.2011.207
Van der Slikke EC, Star BS, de Jager VD, et al. A high urea-to-creatinine ratio predicts long-term mortality independent of acute kidney injury among patients hospitalized with an infection. Sci. Rep. 2020;10(1):15649. doi: 10.1038/s41598-020-72815-9.
Brookes EM, Power DA. Elevated serum urea-to-creatinine ratio is associated with adverse inpatient clinical outcomes in non-end stage chronic kidney disease. Sci Rep. 2022;12(1):20827. doi: 10.1038/s41598-022-25254-7
Vanholder R, Gryp T, Glorieux G. Urea and chronic kidney disease: the comeback of the century? (in uraemia research). Nephrol Dial Transplant. 2018;1;33(1):4-12. doi: 10.1093/ndt/gfx039
Hager MR, Narla AD, Tannock LR. Dyslipidemia in patients with chronic kidney disease. Rev Endocr Metab Disord. 2017;18:29-40. doi: 10.1007/s11154-016-9402-z
Tsimihodimos V, Mitrogianni Z, Elisaf M. Dyslipidemia associated with chronic kidney disease. Open Cardiovasc Med J. 2011;5:41-48. doi: 10.2174/1874192401105010041
Faraji S, Alizadeh M. Mechanistic Effects of Vitamin D Supplementation on Metabolic Syndrome Components in Patients with or without Vitamin D Deficiency. J Obes Metab Syndr. 2020;29(4):270-280. doi: 10.7570/jomes20003
Asano L, Watanabe M, Ryoden Y, et al. Vitamin D Metabolite, 25-Hydroxyvitamin D, Regulates Lipid Metabolism by Inducing Degradation of SREBP/SCAP. Cell Chem Biol. 2017;24(2):207-217. doi:10.1016/j.chembiol.2016.12.017
Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003;111(12):1805-1812.
Roffe-Vazquez DN, Huerta-Delgado AS, Castillo EC, et al. Correlation of Vitamin D with Inflammatory Cytokines, Atherosclerotic Parameters, and Lifestyle Factors in the Setting of Heart Failure: A 12-Month Follow-Up Study. Int J Mol Sci. 2019;20(22):5811. doi: 10.3390/ijms20225811
Lee J. Nitric oxide in the kidney: its physiological role and pathophysiological implications. Electrolyte Blood Press. 2008;6(1):27-34.
Ortiz PA, Garvin JL. Role of nitric oxide in the regulation of nephron transport. Am J Physiol Renal Physiol. 2002;282:F777–F784.
Wolf ST, Jablonski NG, Ferguson SB, Alexander LM, Kenney WL. Four weeks of vitamin D supplementation improves nitric oxide-mediated microvascular function in college-aged African Americans. Am J Physiol Heart Circ Physiol. 2020;319(4):H906-H914. doi: 10.1152/ajpheart.00631.2020
Omar HS, Taha FM, Fouad S, et al. The association between vitamin D levels and oxidative stress markers in Egyptian Behcet’s disease patients. Orphanet J Rare Dis. 2022;17:264. doi: 10.1186/s13023-022-02416-4
Gupta S, Goyal P, Feinn RS, et al. Role of Vitamin D and Its Analogues in Diabetic Nephropathy: A Meta-analysis. Am J Med Sci. 2019;357:223-229. doi: 10.1016/j.amjms.2018.12.005
Renke G, Starling-Soares B, Baesso T, Petronio R, Aguiar D, Paes R. Effects of Vitamin D on Cardiovascular Risk and Oxidative Stress. Nutrients. 2023;15(3):769. doi: 10.3390/nu15030769
Vaidya A, Williams JS. The relationship between vitamin D and the renin-angiotensin system in the pathophysiology of hypertension, kidney disease, and diabetes. Metabolism. 2012;61(4):450-458. doi:10.1016/j.metabol.2011.09.007
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 European Journal of Clinical and Experimental Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
